Chemoinformaics analysis of IPOLAMIIDE
Molecular Weight | 406.384 | nRot | 4 |
Heavy Atom Molecular Weight | 380.176 | nRig | 17 |
Exact Molecular Weight | 406.148 | nRing | 3 |
Solubility: LogS | -1.677 | nHRing | 2 |
Solubility: LogP | -0.915 | No. of Aliphatic Rings | 3 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 54 | No. of Aliphatic Hetero Cycles | 2 |
No. of Heavy Atom | 28 | No. of Aromatic Carbocycles | 0 |
nHetero | 11 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 1 |
No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 1 |
No. of Carbon atom | 17 | No. of Saturated Rings | 2 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 11 | No. of Arom Bond | 0 |
nHA | 11 | APOL | 54.5486 |
nHD | 6 | BPOL | 33.8954 |
QED | 0.264 |
Synth | 4.878 |
Natural Product Likeliness | 2.798 |
NR-PPAR-gamma | 0.002 |
Lipinski | Rejected |
Pfizer | Accepted |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.001 |
Pgp-sub | 0.863 |
HIA | 0.923 |
CACO-2 | -6.239 |
MDCK | 0.000127745 |
BBB | 0.21 |
PPB | 0.232739 |
VDSS | 0.343 |
FU | 0.528758 |
CYP1A2-inh | 0.01 |
CYP1A2-sub | 0.958 |
CYP2c19-inh | 0.012 |
CYP2c19-sub | 0.344 |
CYP2c9-inh | 0.003 |
CYP2c9-sub | 0.051 |
CYP2d6-inh | 0.003 |
CYP2d6-sub | 0.078 |
CYP3a4-inh | 0.014 |
CYP3a4-sub | 0.04 |
CL | 1.326 |
T12 | 0.751 |
hERG | 0.052 |
Ames | 0.092 |
ROA | 0.009 |
SkinSen | 0.066 |
Carcinogencity | 0.794 |
EI | 0.052 |
Respiratory | 0.215 |
NR-Aromatase | 0.07 |
Antiviral | Yes |
Prediction | 0.686103 |